Phase IV An Evaluator-Blind Controlled Parallel-Group Study To Assess Efficacy And Safety Of Skinoren 15% Gel And Differin 0,1% Gel For The Treatment And Maintenance Treatment Of Facial Acne Vulgaris And Late-Type Acne In Females.

Trial Profile

Phase IV An Evaluator-Blind Controlled Parallel-Group Study To Assess Efficacy And Safety Of Skinoren 15% Gel And Differin 0,1% Gel For The Treatment And Maintenance Treatment Of Facial Acne Vulgaris And Late-Type Acne In Females.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2015

At a glance

  • Drugs Azelaic acid (Primary) ; Adapalene
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Acronyms SKADI
  • Most Recent Events

    • 13 Jan 2014 New source identified and integrated (DRKS00003170; German Clinical Trials Register).
    • 23 Mar 2012 New source identified and integrated (EudraCT2011-000152-42; European Clinical Trials Database).
    • 19 Aug 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top